Gastric cancer (GC) is a common malignancy characterized by the absence of reliable prognostic indicators and effective therapeutic targets.
Claudin-9 (CLDN9) has been demonstrated to be upregulated in various cancers.
However, its prognostic value, biological function, and regulatory mechanisms in GC remain unclear.
Therefore, this study aimed to elucidate the role of
